Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Half-year Report

6 Dec 2016 07:00

RNS Number : 0225R
Imaginatik PLC
06 December 2016
Β 

Imaginatik plc

("Imaginatik" or "the Company")

Interim Results

Β 

Imaginatik plc (AIM: IMTK.L), the innovation company, announces its unaudited results for the six months ended 30 September 2016.

Β 

Highlights

Considerably reduced loss after tax of Β£0.26m (2015: Β£0.41m), despite impact of adverse currency movementsRecognised revenue steady at Β£1.84m (2015: Β£1.96m)Deferred revenue increased 16% to Β£3.35m at 30 September 2016 (30 September 2015: Β£2.88m) Overall bookings of Β£1.95m (2015: Β£2.2m)Good level of customer renewals and signing of four new customersInitiation of partner programme in US and Europe, resulting in potential significant expansion of market reachKey Senior Management appointment in the US to support technology expansionSuccessfully completed a Placing and Open Offer in June 2016, raising Β£1.67m gross, to enable further investment in the business

Β 

* At constant currency, US$ to Β£ exchange rate of 1.325.

Β 

Matt Cooper, Non-Executive Chairman, commented: "Imaginatik delivered a steady first half of the year, substantially reducing trading losses while once again securing a good level of customer renewals and new customer wins. We continue to see evidence that our acknowledged leadership of the innovation industry is resulting in growing interest in our business - both from a partnering and customer perspective.

Β 

"We have entered the second half of the year with a healthy pipeline of new business opportunities and have closed three new clients in the start of the second half of the year. Having built a unique offering within the international innovation marketplace we are confident we have the foundations in place for future success."

Β 

For further information please contact:

Β 

Imaginatik plc

Tel: 01329 243 243

Matt Cooper Non-Executive Chairman

Ralph Welborn, CEO

Shawn Taylor, CFO

Β 

Β 

Β 

finnCap Ltd

Tel: 020 7220 0500

Jonny Franklin-Adams/Giles Rolls

Β 

Β 

Β 

Alma PR

Tel: 020 8004 4218

Hilary Buchanan/ Caroline Forde

Β 

Β 

About Imaginatik

Β 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as PwC, Novartis, The Chubb Group of Insurance Companies, Exxon Mobil, Altria, Shell, Mayo Clinic, Goodyear, the Yorkshire Building Society, Caterpillar and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

Β 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE: IMTK.L) with offices in Boston, MA, and Fareham, UK. For more information visitΒ www.imaginatik.com.

Β 

Β 

Introduction

Β 

Imaginatik delivered a steady first half of the year, substantially reducing trading losses while once again securing a good level of customer renewals and new customer wins. The loss after tax reduced to Β£0.26m (2015: Β£0.41m). Approximately half of the loss after tax is attributable to adverse foreign exchange movements arising as a result of the strong US dollar. Recognised revenue was Β£1.84m for the period (2015: Β£1.96m) with overall bookings of Β£1.95m (2015: Β£2.2m).

Β 

Our unique ability to provide consultancy services but also deliver programmes through our software continues to be a powerful differentiator for us in the innovation market. We continue to implement innovation programmes with some of the world's leading brands across a broad range of sectors, generating tangible results for our customers.

Β 

Four new customers were added in the half, including a global supplier of railroad and transit system products and services, a US-based global healthcare company, a global medical company specialising in eye care, and a provider of engineering, consulting and project management services for infrastructure projects. Each of these new global customers provides an opportunity for future revenue growth.

Β 

The Company has now begun the investment of the funds raised via the Institutional Placing and Open Offer completed in June 2016, investing in our sales and marketing resources and technology suite to provide an ever more comprehensive platform for future growth.

Β 

We have also begun building an extended partnership programme in both the US and Europe, which we believe has the potential to significantly expand our market reach. We have been encouraged by the calibre of partners approaching us, which we believe is an indication of the growing market awareness of the need for innovation and of our leading position within the innovation market. We will update investors further once these partnership agreements have been concluded.

Β 

Financial Review

Β 

Total recognised revenue for the six months to 30 September 2016 was Β£1.84m (2015: Β£1.96m). Revenue recognised from the US in the period accounted for approximately 68% of the total (2015: 86%) with the balance derived from 'Rest of World', primarily the European market. Revenues recognised from consultancy services fell from approximately 23% in 2015 to 19% in the period under review, with the remainder derived from Technology.

Β 

Gross bookings in the period were slightly lower at Β£1.95m (2015: Β£2.2m at constant currency). In the period under review, 41% of bookings were from up-selling our software and consultancy services into existing customers, 9% from selling into new customers, and 50% from renewals business (2015: 50%: 4%: 46% respectively).

Β 

Deferred revenue increased to Β£3.35m at 30 September 2016 (30 September 2015: Β£2.88m) a 16% increase year on year. Of the 14 contracts that came up for renewal, 10 were successfully secured on annual or multi year extensions, with four small clients choosing either not to renew or deferring that decision pending internal restructuring. These four clients amounted to less than Β£0.1m in total revenues. Of the renewals secured, most were contracted at the same levels or higher than the 2015 value. (2015: 14 secured out of 17 possible renewals).

Β 

We have approximately 45% of our customer base now on multi-year contracts (2015: 52%) with a further 16 clients set for renewal in our second half. We now have 45 clients either on multi-year contracts or currently carrying out consultancy engagements (2015: 44).

Β 

We secured four new customers in the period (2015: 3), two of which were added on an annual contract (2015: 0) and two on consulting engagements (2015: 3). The annualised value of our renewals stood at Β£3.24m at period end (2015: Β£3.17m at constant currency), and we look forward to growing this further as we progress through the second half of the year.

Β 

Capitalised internal development costs amounted to Β£0.16m (2015: Β£0.14m) as we continue to invest in building out our suite of technology offerings, including an enhanced mobile tool and further decision-making analytic tools.

Β 

We have been successful in securing an R&D tax credit from HMRC amounting to Β£0.21m (2015: Β£0.16m), reflecting the ongoing pioneering nature of certain elements of our R&D efforts in building out our software platform.

Β 

Administrative expenses decreased to Β£2.23m (2015: Β£2.37m), reflecting the ongoing focus within the Company on containing costs across the business. This factor, combined with the additional R&D tax credit generated, relative to 2015, has resulted in a substantially reduced trading loss, this is in spite of marginally lower revenues and a lower US$ exchange rate for the last few months of the period.

Β 

The loss after tax on ordinary activities for the period decreased considerably compared to the prior year to Β£0.26m (2015: Β£0.41m, 2014: Β£0.70m). The loss includes Β£0.11m of foreign exchange losses, arising from the revaluation of $US denominated deferred revenue balances offset to some extent by the revaluation of $US denominated receivables.

Β 

Cash outflows from operating activities showed an increase to Β£1.2m (2015: Β£0.56m), largely as a function of the increase in trade debtors towards the period end, following a series of large contract renewals in the final weeks of the period. Resulting cash balances at 30 September 2016 were Β£0.19m (30 September 2015: Β£0.04m). The cash position has improved post period end, increasing to Β£0.4m at 5 December 2016, as a result of a proportion of the trade receivables having been received by the Company with additional funds due imminently.

Β 

In June 2016, the Company raised Β£1.58m gross via a Placing and a further Β£0.09m via an Open Offer to shareholders. These funds are being used to add additional sales and marketing headcount, to increase the marketing spend to build the Company's brand in the marketplace, to continue to build new technology capabilities to capture growing market demand.

Β 

Operational Review

Β 

Sales and Marketing

Β 

Marketing efforts during the period have focused on expanding our digital footprint. Changes to our website's homepage are a first-step toward a full re-design which is expected to be launched in early 2017. New email marketing, digital advertising, and content marketing programs have generated a substantially higher base of website visitors and as a result more inbound leads. Both Sales and Marketing have added incremental headcount in the period, allowing us to expand and sustain our activities in these areas.

Β 

During the period, we launched a Client Community portal for our customers, where they can learn from each other and network with their peers at other companies. The online community portal has been complemented by a clients-only webinars program. These are facilities that our client community finds extremely valuable. We believe these efforts will further strengthen our retention rates and at the same time generate good upsell opportunities.

Β 

Partnership programme

Β 

In order to create new sales channel leverage, our partnerships programme has been expanded and systematised, with the creation of a full-time Business Development role focused on developing a range of channel partners. Several important market-access and go-to-market partnerships are in advanced development in both the US and Europe.

Β 

Consultancy

Β 

We are pleased to report continued progress in the consulting division, including successfully growing our footprint with several existing customers and expanding the range of our consultancy engagements.

Β 

Examples of customer engagements successfully delivered in the first half of the year include:

Β 

A Global Nutrition company

In the face of strong competition within the highly regulated healthcare market the client decided they needed to reshape their innovation portfolio of opportunities in order to address the new market challenges ahead of them, engaging with Imaginatik to help them do so. With a superior product and a strong science-based positioning they nevertheless believed that that was not sufficient to guarantee future success. The client's objective was to identify a range of product innovation concepts for their EMEA markets, and once identified to take the most promising forward.

In a series of workshops Imaginatik ledΒ the cross-functional,Β global team through a series of Breakthrough Ideation experiencesΒ to target this critical issue. The team began by sharing overviews on critical topics such as the latest scientific developments, competitive threats and opportunities, consumer insights, industry trends and new regulation considerations, all of which helped build the foundation for strong breakthrough ideas. Imaginatik consultants helped elevate client thinking through a myriad of provocative exercises and highly creative stimuli that included innovations in different industries, biomimicry examples - looking at naturally occurring innovations within nature, interesting consumer trends and unconventional startups. After identifying a large range of interesting ideas Imaginatik took the participants through a rigorous process of combination, clustering and prioritising ideas that culminated with the top concepts being identified. The results of this work were entered in Imaginatik's Innovation Central platform for statistical comparison using its proprietary Head-to-Head review tool.

The final outcome of this work was a series of fully built, high-impact concepts ranging from packaging innovation all the way through to potential new product formulations. The client was provided with a clear path forward together with executive alignment and set for rapid implementation.

Β 

A European food services and facilities management company

Β 

The client is one of the largest providers of food and facilities management in the world, with 420,000 employees; in excess of revenues of €15.3bn and a global clientele operating in a dispersed and complex ecosystem across 80 countries.

Β 

Imaginatik began its engagement with the client in early 2016, under an initial three year contract. During this first year, and with assistance from Imaginatik consultants, the client focused on setting up a small team with a remit to establish the ideation platform internally, generate interest internally and to foster innovation management expertise within the client in the most visible areas. During 2016 the client's platform usage grew very quickly, with numerous high visibility events being run, with activity levels growing substantially as their competency developed.

Β 

As the client moved further into the innovation programme, we have helped the client expand the technology into seven different languages, supporting all major emerging markets as well as supporting new regulatory compliance requirements that have emerged. Imaginatik has now replaced other platform competitors in three South American geographies of the client's operations. A multi-geography mobile support product for the Imaginatik innovation platform for staff has subsequently been launched, to enable immediate capture of customer feedback and access global best practice guidance.

Β 

The next phase of development will see the client and Imaginatik piloting open innovation with some of the client's major customers across the globe. In addition, the client is planning to add a further 20 additional languages over the next two years.

Β 

Technology

Β 

Expansion of our technology platform, Innovation Central, continues to be a key focus for the Company. We are delighted to have welcomed in recent months a key Senior Management hire in David Boghossian. David was previously Co-founder and CEO of PowerSteering Software, the cloud-based project portfolio management software business and has been a long-term Growth and Innovation Adviser. He brings considerable innovation and technology experience and will play an important role in further developing our product portfolio, covering the combination of technology and consulting.

Β 

We continue to develop our user interface of Innovation Central to ensure that our technology is intuitive and easy to use. We launched a new version of our mobile offering this month, providing easy access to Innovation Central functionality for users on iOS and Android devices. We are also continuing to expand our Innovation Analytics capabilities focusing on managing networks of ideas and comments at scale, measuring diversity of thought in innovation programmes, and providing advice to innovation leaders about the maturity of challenges. Our progress in Innovation Analytics helps innovation leaders drive their innovation programmes, assisting them to make smarter, evidence-based decisions.

Β 

Outlook

Β 

The Company has entered the second half of the year with a healthy pipeline of new business opportunities and has closed three new clients in the start of the second half of the year. Having built a unique offering within the international innovation marketplace we are confident we have the foundations in place for future success.

Β 

Β 

Β 

Condensed Unaudited Consolidated Interim Statement of Comprehensive Income

For the six months ended 30 September 2016

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Unaudited 6 months to 30 Sept

2016

Unaudited 6 months to 30 Sept

2015

Audited year to 31 March 2016

Β 

Note

Β£'000

Β£'000

Β£'000

Β 

Β 

Β 

Β 

Β 

Revenue

5

1,836

1,960

3,893

Β 

Β 

Β 

Β 

Β 

Cost of sales

Β 

(92)

(131)

(232)

Β 

Β 

Β 

Β 

Β 

Gross profit

Β 

1,744

1,829

3,661

Β 

Β 

Β 

Β 

Β 

Administrative expenses

Β 

(2,228)

(2,366)

(4,720)

Β 

Β 

Β 

Β 

Β 

Other operating income

Β 

28

-

14

Β 

Β 

Β 

Β 

Β 

Operating loss before financing and taxation

Β 

(456)

(537)

(1,045)

Β 

Β 

Β 

Β 

Β 

Operating loss before foreign exchange losses

Β 

(344)

(498)

(895)

Foreign exchange losses

Β 

(112)

(39)

(150)

Β 

Β 

Β 

Β 

Β 

Finance income/(costs)

Β 

(21)

(35)

(65)

Β 

Β 

Β 

Β 

Β 

Loss on ordinary activities before taxation

Β 

(477)

(572)

(1,110)

Β 

Β 

Β 

Β 

Β 

Taxation

Β 

215

165

165

Β 

Β 

Β 

Β 

Β 

Loss on ordinary activities for the period

Β 

(262)

(407)

(945)

Β 

Β 

Β 

Β 

Β 

Basic and diluted loss per share (p)

4

(0.22)

(0.51)

(1.15)

Β 

All amounts are attributable to equity holders of the parent, and all arise from continuing operations. No amounts were recognised directly in equity, and therefore no separate statement of comprehensive income has been presented.

Β 

Β 

Β 

Imaginatik Plc

Condensed Unaudited Consolidated Interim Statement of Financial Position

As at 30 September 2016

Β 

Restated

Β 

Β 

Unaudited

30 Sept

2016

Unaudited

30 Sept

2015

Audited 31 March 2016

Β 

Note

Β£'000

Β£'000

Β£'000

ASSETS

Β 

Β 

Β 

Β 

Non-current assets

Β 

Β 

Β 

Β 

Property, plant and equipment

Β 

16

26

19

Intangible assets

Β 

579

459

493

Trade & other receivables

Β 

582

547

273

Β 

Β 

1,177

1,032

785

Current assets

Β 

Β 

Β 

Β 

Trade and other receivables

Β 

2,373

1,808

1,403

Cash and cash equivalents

Β 

189

38

23

Β 

Β 

2,562

1,846

1,426

Total assets

Β 

3,739

2,878

2,211

Β 

Β 

Β 

Β 

Β 

EQUITY AND LIABILITIES

Β 

Β 

Β 

Β 

Equity

Β 

Β 

Β 

Β 

Issued capital

6

4,042

3,370

3,374

Share premium

6

7,764

6,876

6,883

Share option reserve

6

1,163

1,122

1,143

Retained earnings

6

(13,079)

(12,279)

(12,817)

Total equity attributable to equity holders of the parent

Β 

(110)

(911)

(1,417)

Β 

Β 

Β 

Β 

Β 

Liabilities

Β 

Β 

Β 

Β 

Non-current liabilities

Β 

Β 

Β 

Β 

Other payables

Β 

1,068

1,105

736

Total non-current liabilities

Β 

1,068

1,105

736

Β 

Β 

Β 

Β 

Β 

Current liabilities

Β 

Β 

Β 

Β 

Trade and other payables

Β 

2,781

2,684

2,892

Β 

Β 

2,781

2,684

2,892

Total liabilities

Β 

3,849

3,789

3,628

Total equity and liabilities

Β 

3,739

2,878

2,211

Β 

Β 

Β 

Β 

Β 

Β 

Imaginatik Plc

Condensed Unaudited Consolidated Interim Statement of Cash Flows

For the six months ended 30 September 2016

Β 

Β 

Note

Unaudited

6 months

to 30 Sept

2016

Unaudited

6 months to 30 Sept 2015

Audited Year to 31 March 2016

Β 

Β 

Β£'000

Β£'000

Β£'000

Β 

Β 

Β 

Β 

Β 

Cash outflows from operating activities

7

(1,214)

(558)

(460)

Β 

Β 

Β 

Β 

Β 

Investing activities

Β 

Β 

Β 

Β 

Acquisition of property, plant and equipment

Β 

(5)

-

(1)

Acquisition of intangible assets

Β 

(163)

(141)

(264)

Net cash used in investing activities

Β 

(168)

(141)

(265)

Β 

Β 

Β 

Β 

Β 

Net cash flow before financing activities

Β 

(1,382)

(699)

(725)

Β 

Β 

Β 

Β 

Β 

Financing activities

Β 

Β 

Β 

Β 

Net proceeds from the issue of share capital

Β 

1,549

612

623

Net cash generated from financing activities

Β 

1,549

612

623

Β 

Β 

Β 

Β 

Β 

Net (decrease)/increase in cash and cash equivalents

Β 

166

(87)

(102)

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents at start of period

Β 

23

125

125

Cash and cash equivalents at end of period

Β 

189

38

23

Β 

Β 

Imaginatik Plc

Condensed Unaudited Consolidated Interim Statement of Changes in Equity

For the six months ended 30 September 2016

Β 

Β 

Restated Share capital

Β 

Restated Share premium

Share option reserve

Retained earnings

Total

Β 

Β 

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 1 April 2015

3,154

6,480

1,076

(11,872)

(1,162)

Β 

Β 

Β 

Β 

Β 

Β 

Loss for the period

-

-

-

(407)

(407)

Share option costs

-

-

46

-

46

Shares issued

216

396

-

-

612

Β 

216

396

46

(407)

251

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 30 September 2015

3,370

6,876

1,122

(12,279)

(911)

Β 

Β 

Β 

Β 

Β 

Β 

Loss for the period

-

-

-

(538)

(538)

Share option costs

-

-

21

-

21

Shares issued

4

7

-

-

11

Β 

4

7

21

(538)

(506)

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 31 March 2016

3,374

6,883

1,143

(12,817)

(1,417)

Β 

Β 

Β 

Β 

Β 

Β 

Loss for the period

-

-

-

(262)

(262)

Share option costs

-

-

20

-

20

Shares issued

668

881

-

-

1,549

Β 

668

881

20

(262)

1,307

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 30 September 2016

4,042

7,764

1,163

(13,079)

(110)

Β 

Β 

Imaginatik Plc

Notes to the Condensed Unaudited Consolidated Interim Financial Statements

For the six months ended 30 September 2016

1. Background

Β 

Imaginatik plc (the "Company") is a company domiciled in the United Kingdom. The unaudited condensed consolidated interim financial statements of the Company for the six months ended 30Β September 2016 comprise the Company and its subsidiary (together referred to as the "Group").

Β 

The condensed consolidated interim financial statements were authorised for issuance on 5 December 2016.

Β 

The interim financial statements are not statutory accounts for the purposes of S435 of the Companies Act 2006. The comparative figures for the year ended 31 March 2016 are not the Company's statutory accounts for that financial year. The financial information for the year ended 31 March 2016 is based on the statutory accounts for the financial year ended 31 March 2016. Those accounts have been reported on by the Company's auditors and delivered to the Registrar of Companies. The report of the auditors was (i) unqualified, (ii) did not include a reference to any matters to which the auditors drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498(2) or (3) of the Companies Act 2006.

Β 

2. Basis of preparation

Β 

The financial statements are presented in pounds sterling, rounded to the nearest thousand, unless stated otherwise.Β They are prepared on the historical cost basis.

Β 

These interim financial statements have been prepared using accounting policies based on IFRS as adopted by the European Union (including IAS and interpretations issued by the International Financial Reporting Interpretations Committee ("IFRIC")) that are expected to be applicable for the full reporting year in 2016. These remain subject to ongoing amendment and/or interpretation and are therefore subject to possible change. Consequently, information contained in these interim financial statements may need updating for any subsequent amendments to IFRS, or for any new standards that the Group may elect to adopt early.

Β 

The accounting policies have been applied consistently throughout the Group for purposes of these condensed unaudited consolidated interim financial statements.

Β 

Β 

3. Prior period adjustment

Β 

An error was found in the prior period share capital and share premium reserve. The September 2015 comparative figures have been restated to reclassify this difference.

Β 

Β 

4. Loss per share

Β 

Basic loss per share

The calculation of basic loss per share for the period ended 30 September 2016 was based on the loss attributable to ordinary shareholders of Β£262,000 (period ended 30 September 2015:Β Β£407,000; year ended 31 March 2016: Β£945,000) and a weighted average number of ordinary shares outstanding during the period ended 30 September 2016 of 121,204,394 (period ended 30 September 2015:Β 78,898,129; year ended 31 March 2016: 81,948,369).

Β 

Β 

4. Loss per share (continued)

Β 

Diluted loss per share

The options in place during the periods ended 30 September 2016 and 30 September 2015 and during the year ended 31 March 2016 are considered to have an anti-dilutive effect. Therefore, basic and diluted loss per share is the same for each of the three periods.

Β 

Β 

5. Segmental reporting

Β 

Management currently identifies the Group's two revenue streams as its operating segments. These operating segments are monitored by the Group's chief operating decision maker. For these operating segments only revenues are reported to the Group's chief operating decision maker as results; other costs and assets and liabilities cannot be reliably allocated to the operating segments.

Β 

Β 

Unaudited

6 months

to 30 Sept

2016

Unaudited 6 months to 30 Sept 2015

Audited Year to

31 March 2016

Β 

Β£'000

Β£'000

Β£'000

Segmental revenue

Β 

Β 

Β 

Technology

1,491

1,503

2,778

Consultancy

345

457

1,115

Β 

1,836

1,960

3,893

Β 

All other information presented to the Chief operating decision maker is the same as is reported in these financial statements.

Β 

The Group's revenues from external customers and its non-current assets are divided into the following geographical areas:

Β 

Β 

Unaudited

6 months

to 30 Sept

2016

Unaudited

6 months to 30 Sept

2015

Audited Year to

31 March 2016

Β 

Β£'000

Β£'000

Β£'000

Segmental revenue

Β 

Β 

Β 

United States of America

1,240

1,682

2,977

Rest of the world

596

278

916

Β 

1,836

1,960

3,893

Segmental non-current assets

Β 

Β 

Β 

United States of America

399

493

219

Rest of the world

778

539

566

Β 

1,177

1,032

785

Β 

Revenues from external customers have been identified on the basis of the customer's geographical location. Non-current assets are allocated based on their physical location.

Β 

The Group has one customer (2015: one customer), who accounted for revenues of Β£214,000 (2015: Β£227,000), which amounted to more than 10% of Group revenues. These revenues arose in the Technology segment.

Β 

Β 

Β 

6. Share Capital and Reserves

Β 

Β 

Unaudited

6 months

to 30 Sept

2016

Restated

Unaudited 6 months

to 30 Sept 2015

Audited Year to

31 March

Β 2016

Β 

Β£'000

Β£'000

Β£'000

Share Capital

Β 

Β 

Β 

At the beginning of the period

3,374

3,154

3,154

Shares issued

668

216

220

At the end of the period

4,042

3,370

3,374

Β 

Β 

Β 

Β 

Share premium

Β 

Β 

Β 

At the beginning of the period

6,883

6,480

6,480

Shares issued in the period, net of expenses

881

396

403

At the end of the period

7,764

6,876

6,883

Β 

Β 

Β 

Β 

Share option reserve

Β 

Β 

Β 

At the beginning of the period

1,143

1,076

1,076

Share-based payments

20

46

67

At the end of the period

1,163

1,122

1,143

Β 

Β 

Β 

Β 

Retained earnings

Β 

Β 

Β 

At the beginning of the period

(12,817)

(11,872)

(11,872)

Loss for the period

(262)

(407)

(945)

At the end of the period

(13,079)

(12,279)

(12,817)

Β 

Β 

New shares allotted

Issue costs relating to the above placings were Β£119,000 (period ended 30 September 2015: Β£38,000; year ended 31 March 2016: Β£38,000) and have been deducted from the share premium account.

Β 

Β 

7. Cash flows from operating activities

Β 

Β 

Β 

Β 

Β 

Β 

Unaudited

6 months

to 30 Sept

2016

Unaudited 6 months

to 30 Sept 2015

Audited Year to

31 March 2016

Β 

Β£'000

Β£'000

Β£'000

Β 

Β 

Β 

Β 

Operating loss

(456)

(537)

(1,045)

Depreciation of tangible fixed assets

8

10

17

Amortisation of intangible fixed assets

78

74

163

Share-based payment expense

20

45

67

Operating cash flows before movements in working capital

(350)

(408)

(798)

(Increase) / decrease in trade and other receivables

(1,279)

(359)

320

Increase / (decrease) in payables

221

79

(82)

Net movement in working capital

(1,058)

(280)

238

Cash used by operations

(1,408)

(688)

(560)

Corporation tax received

215

165

165

Net interest expense

(21)

(35)

(65)

Net cash from operating activities

(1,214)

(558)

(460)

Β 

Β 

8. Availability of announcement

Β 

Copies of this announcement will be available from the Company's offices at Carnac Cottage, Cams Hall Estate, Fareham, Hampshire, PO16 8UU and from its website, www.imaginatik.com.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR TABMTMBMMTLF
Date   Source Headline
9th Jun 201710:54 amRNSProposed Placing
27th Apr 20177:00 amRNSChange of Registered Office
25th Apr 20177:00 amRNSTrading Update
24th Apr 20178:16 amRNSHolding(s) in Company
27th Feb 201710:35 amRNSHolding(s) in Company
14th Dec 20169:31 amRNSHolding(s) in Company
9th Dec 201611:47 amRNSHolding(s) in Company
6th Dec 20167:00 amRNSHalf-year Report
25th Nov 20169:56 amRNSHolding(s) in Company
24th Nov 20167:00 amRNSTrading Update and Notice of Results
13th Sep 20162:29 pmRNSResult of AGM
13th Sep 20167:00 amRNSGrant of Options
17th Aug 20167:00 amRNSFinal Results
10th Aug 20163:21 pmRNSHolding(s) in Company
21st Jul 20164:46 pmRNSHolding(s) in Company
28th Jun 201612:12 pmRNSHolding(s) in Company
27th Jun 201611:45 amRNSHolding(s) in Company
24th Jun 20167:00 amRNSResult of Open Offer and Total Voting Rights
16th Jun 201610:35 amRNSHolding(s) in Company
13th Jun 201611:20 amRNSResult of General Meeting
25th May 20167:00 amRNSFundraising
17th May 201612:26 pmRNSFunding Update
17th May 201610:51 amRNSPress Speculation
29th Apr 20169:09 amRNSHolding(s) in Company
28th Apr 201610:54 amRNSHolding(s) in Company
27th Apr 20169:04 amRNSHolding(s) in Company
13th Apr 20161:36 pmRNSHolding(s) in Company
12th Apr 201610:18 amRNSHolding(s) in Company
6th Apr 20164:51 pmRNSHolding(s) in Company
6th Apr 20161:23 pmRNSPress Speculation
9th Mar 20167:00 amRNSTrading Update
26th Jan 201610:03 amRNSHolding(s) in Company
21st Jan 20162:51 pmRNSHolding(s) in Company
5th Jan 20167:00 amRNSDirector Loan
17th Dec 20158:20 amRNSHolding(s) in Company
15th Dec 20157:00 amRNSGrant of Options
10th Dec 20157:00 amRNSHalf Yearly Report
13th Nov 20153:35 pmRNSWarrant Exercise
9th Nov 20153:57 pmRNSTrading update
6th Nov 20154:13 pmRNSHolding(s) in Company
23rd Sep 20153:07 pmRNSResult of AGM
16th Sep 20157:00 amRNSDirector Loan
14th Sep 20155:33 pmRNSHolding(s) in Company
1st Sep 20154:34 pmRNSNotice of AGM
1st Sep 20152:23 pmRNSHolding(s) in Company
24th Aug 20157:00 amRNSHolding(s) in Company
10th Aug 20152:20 pmRNSHolding(s) in Company
6th Aug 20151:41 pmRNSHolding(s) in Company
3rd Aug 201512:05 pmRNSHolding(s) in Company
30th Jul 20151:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.